secwatch.observer — SEC 8-K summary
======================================

Issuer:     Y-mAbs Therapeutics, Inc. (—)
CIK:        0001722964
Form:       8-K
Filed at:   2024-03-14T23:59:59+00:00
Accession:  0001104659-24-034340
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Y-mAbs Therapeutics CFO Bo Kruse resigns; search for successor underway
-----------------------------------------------------------------------

- Bo Kruse informed Y-mAbs of his resignation as CFO, effective upon appointment of a successor and then as employee on July 31, 2024.
- He will remain CFO until successor is identified and joins the company; then continue as non-executive employee through July 31.
- Resignation is not due to any disagreement with the company's operations, policies, or practices.
- Company has commenced a search process for a new CFO.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1722964/000110465924034340/0001104659-24-034340-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1722964/000110465924034340/tm248807d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-034340

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer